Nasdaq grts.

Nov 15, 2023 · The average trading volume of GRTS on November 15, 2023 was 2.18M shares. GRTS) stock’s latest price update. Gritstone Bio Inc (NASDAQ: GRTS)’s stock price has gone rise by 8.72 in comparison to its previous close of 1.37, however, the company has experienced a -11.86% decrease in its stock price over the last five trading days. Aug 4, 2022 · Second Quarter 2022 Financial Results. Cash, cash equivalents, marketable securities and restricted cash were $159.2 million as of June 30, 2022, compared to $223.5 million as of December 31, 2021 ... EMERYVILLE, Calif., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the …Web5 ต.ค. 2566 ... The average one-year price target for Gritstone Bio (NASDAQ:GRTS) has been revised to 10.71 / share. This is an increase of 22.09% from the ...Gritstone bio, Inc. Common Stock (GRTS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Web

(Nasdaq: GRTS), a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, today announced that Andrew ...

EMERYVILLE, Calif., Oct. 17, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...

EMERYVILLE, Calif., Jan. 24, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...EMERYVILLE, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today ...clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was ...6 ธ.ค. 2564 ... (Nasdaq: GRTS), a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, and CEPI ...Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases.

Find out why GRTS stock is a Hold. ... (NASDAQ:GRTS) in the spotlight. The company is advancing its pipeline on several fronts, has a collaboration deal with a well-known drug maker, and its lead ...

Vaccine-developer Gritstone bio ( NASDAQ: GRTS) trended higher on Tuesday after B. Riley launched its coverage with a Buy rating and a 12-month target of $8 per share, noting its prospects in ...

Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases.Get the latest GRTS (GRTS) real-time quote, historical performance, charts, and ... Home GRTS • NASDAQ. add. Share. GRTS. $1.88. After Hours: $1.93. ( 2.66%)+ ...EMERYVILLE, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of cancer immunotherapies to fight multiple cancer types. Gritstone develops its ...EMERYVILLE, Calif., June 08, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...EMERYVILLE, Calif., Nov. 17, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...

Jan 13, 2022 · Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases. Find the latest analyst research for Gritstone bio, Inc. Common Stock (GRTS) at Nasdaq.com. Gritstone bio, Inc. Common Stock (GRTS) Analyst Research | Nasdaq …WebGritstone Bio Inc (NASDAQ:GRTS) trade information. Sporting -3.50% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on Monday, 11/13/23 when the GRTS stock price touched $1.38 or saw a rise of 25.61%.20 ม.ค. 2564 ... (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer and infectious disease immunotherapies, and ...Dec 4, 2023 · Gritstone Bio Inc (NASDAQ: GRTS)’s stock price has soared by 17.69 in relation to previous closing price of 1.30. Nevertheless, the company has seen a gain of 11.68% in its stock price over the last five trading days. Zacks Investment Research reported 2023-10-16 that Gritstone bio Inc. (GRTS) has been upgraded to a Zacks Rank #2 (Buy ... Feb 10,2023 - GRTS STOCK PRICE DECREASE: Gritstone bio Inc on 02-10-2023 decreased stock price > 10% from $3.26 to $2.90. Dec 15,2022 - GRTS STOCK PRICE INCREASE: Gritstone bio Inc on 12-15-2022 increased stock price > 10% from $3.11 to $3.92. Dec 14,2022 - GRTS STOCK PRICE INCREASE: Gritstone bio Inc on 12-14-2022 increased stock price > 10% ...

EMERYVILLE, Calif., April 04, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today ...

Shares of NASDAQ GRTS opened at $1.37 on Friday. The company has a market capitalization of $130.62 million, a price-to-earnings ratio of -1.10 and a beta of 0.62. The company has a debt-to-equity ...Gritstone bio ( NASDAQ: GRTS) uses its vaccine technology to promote an immune response against a patients cancer or to prevent or treat infectious disease. In late September, 2023, GRTS announced ...About Gritstone bio Gritstone bio, Inc. (Nasdaq: GRTS) is a clinical-stage biotechnology company that aims to create the world’s most potent vaccines. We leverage our innovative vectors and ...Dec 13, 2021 · Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases. EMERYVILLE, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today ...Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases. Gritstone ...Gritstone bio, Inc. (GRTS) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Follow. 2W 10W 9M. 1.3700 +0.0500 (+3.79%) At close: 01:00PM EST. 1.3700 0.00 …WebGRTS Historical Data. Get up to 10 years of daily historical stock prices & volumes. The "Close/Last" is the “adjust consolidated close price”. Data provided by Edgar Online . The net and ...

May 31, 2022 · EMERYVILLE, Calif., May 31, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...

EMERYVILLE, Calif., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...

Based on analysts offering 12 month price targets for GRTS in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases. Gritstone ...EMERYVILLE, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...EMERYVILLE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today ...27 ก.ย. 2566 ... (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world's most potent vaccines, announced today that it was ...Nov 21, 2023 · Eric Enderson. November 21, 2023. In the last trading session, 1.28 million Gritstone Bio Inc (NASDAQ:GRTS) shares changed hands as the company’s beta touched 0.47. With the company’s per share price at $1.32 changed hands at -$0.04 or -2.94% during last session, the market valuation stood at $125.85M. GRTS’s last price was a discount ... The Panera Bread Company is a public company that is traded on the NASDAQ stock market. The majority of its shareholders are financial institutions and mutual fund holders. The remaining shares are owned by direct holders of Panera Bread st...Financials. GRTS has a market cap of $169mn and a cash balance of $153mn. Research and development expenses were $30.5 million for the three months ended March 31, 2023 while general and ...May 3, 2021 · Gritstone bio (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases. There are 196 funds or institutions reporting positions in Gritstone Bio. This is an increase of 42 owner (s) or 27.27% in the last quarter. Average portfolio weight of all funds dedicated to GRTS ...Simon is currently serving on the Board of Directors of Gritstone Oncology (NASDAQ: GRTS) and Sientra (NASDAQ:SIEN). Mr. Simon received a BS degree in ...

Sep 27, 2023 · EMERYVILLE, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, announced ... Here's Why We're Not Too Worried About Gritstone bio's (NASDAQ:GRTS) Cash Burn Situation May 26. Consensus revenue estimates increase to US$46.1m May 13. First quarter 2021 earnings released: EPS US$0.10 (vs US$0.71 loss in 1Q 2020) May 07. Gritstone Oncology EPS beats by $0.41, beats on revenueGritstone bio, Inc. (NASDAQ:GRTS) shares rose 37% to $1.63 in pre-market trading after the company announced it was awarded a BARDA contract to conduct a Phase 2b comparative study evaluating a ...Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases.Instagram:https://instagram. american funds smallcap world fundbarron magazinevanguard retirement 2045lgbt friendly health insurance Insiders seem to have made the most of their holdings by selling US$221k worth of Gritstone bio, Inc. (NASDAQ:GRTS) stock at an average sell price of US$22.10 during the past year. The company's ... cbds stock pricemechanincs bank 3 วันที่ผ่านมา ... Gritstone bio, Inc. Common Stock (GRTS) · GRTS Option $5.00 May 17, 2024. steadily insurance bbb rating A. Gritstone Bio ( GRTS) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 8, 2023 for Q3 and the Actual Revenue was $1.6M, which ...Feb 10,2023 - GRTS STOCK PRICE DECREASE: Gritstone bio Inc on 02-10-2023 decreased stock price > 10% from $3.26 to $2.90. Dec 15,2022 - GRTS STOCK PRICE INCREASE: Gritstone bio Inc on 12-15-2022 increased stock price > 10% from $3.11 to $3.92. Dec 14,2022 - GRTS STOCK PRICE INCREASE: Gritstone bio Inc on 12-14 …